Out of the lab, into the courts

Article Abstract:

The Adelaide biotechnology company BresaGen is planning to terminate the phase-two trial of a potential anti-cancer drug called E21R. The project of E21R was important to the company because of a lucrative collaboration deal it had signed in 2000 with the listed British Biotech to develop the cancer drug.

Author: Quinlivan, Beth
Government regulation, Drugs, Biotechnology industry, Biotechnology industries, Licensing, certification and accreditation, BresaGen Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Now hear this

Article Abstract:

The business growth plans of Neuromonics, in the United States, are presented.

Author: Quinlivan, Beth
Australia, Management dynamics, Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Planning, Medical Instruments & Supplies, Management, Business planning, Medical equipment and supplies industry, Medical equipment industry, Company business management, Business plans, Medical test kit industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ansell thinks bigger

Article Abstract:

The expansion plans of Ansell in China are examined.

Author: Quinlivan, Beth
China, RUBBER AND MISC. PLASTICS PRODUCTS, Rubber industry, Ansell Healthcare Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Planning, Company business planning
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.